Feed / MDXG

MiMedx Group, Inc

MDXG

Healthcare · 4.43 +8.1% today

Dominant mover · weak group confirmationMarket checked 20 Aug, 09:30 GMT-4

Jodie situation report

MDXG dominates a concentrated Medical Technology move.

MDXG accounts for 38.7% of the group's measured movement across 2.4 effective names. all 3 measured members are falling in raw terms, but 3 of 3 session-normalized paths align to the downside. Capital-flow agreement is 1%, so confirmation is not yet clean. No verified headline preceded the measured group move.

MOVE ANATOMY

Is this move genuinely shared?

Session-normalized 5m paths
Role in the moveDominant mover#2 of 3 by movement share
Group movement share38.7%Absolute path energy—not portfolio weight
Relative path-0.56%aligned
Effective breadth2.4 / 3concentrated
Relative alignment3/3downside path · 0 counter-moving
Capital-flow agreement1%not yet clean
SEQUENCE READ

MDXG was the first measured mover. MDXG crossed its material path threshold at 14:25 ET. KMTS, BLCO followed.

EVIDENCE COVERAGE

4 of 4 members in Medical Technology are active. 0 of 4 disclosed connections are confirming.

What would change this read
  • At least 3 of 4 members remain active in the next snapshot.
  • Capital-flow agreement rises above 55%.
  • A filing-linked outsider such as BHC begins moving with the group.

Invalidation: The live read weakens if participation falls to 1 of 4 members or fewer.

Watch this read

Who this business touches

The relationships behind MDXG

Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.

Depends on

WMWaste Management, Inc.supplierFeb 25, 2026 ▾

“The review looked at several areas including: • Air Pollution Control Management • Battery Handling and Disposal • Community Right-to-Know (Hazardous Material Reporting) • Hazardous Waste Management • SARA Title III (Release Reporting) • Solid Waste Managemen…”

IARTIntegra LifeSciences Holdings CcompetitorFeb 25, 2026 ▾

“Our main publicly-traded competitors in the skin substitute market include Integra LifeSciences Holdings Corporation, Organogenesis, Inc., and Smith & Nephew plc, which sell a variety of AWC products, including skin substitutes and placental tissue allografts.”

ORGOFiling-linked namecompetitorFeb 25, 2026 ▾

“Our main publicly-traded competitors in the skin substitute market include Integra LifeSciences Holdings Corporation, Organogenesis, Inc., and Smith & Nephew plc, which sell a variety of AWC products, including skin substitutes and placental tissue allografts.”

Filing peers

VCELPCRXHAE

Companies whose filings use similar operating language.

Open the three relationships above to see Jodie’s filing proof. Pro unlocks 2 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →

What is moving around it

Live connections

MDXG is currently a Early Follower in the organic co-movement group Medical Technology. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.